Clinical Readiness Study (vs. Clinical Trial)
**What it means:** A **"clinical readiness study"** is different from a full clinical trial. It's the work done *before* a trial to make sure the trial can actually happen. This includes: - **Patient ...
Explainers
Plain-English explanations of MEF2C research terms, concepts, and scientific mechanisms.
MicroRNA Therapeutic Advantage (why MUSC chose RNA over gene therapy)
**What it means:** The MUSC team evaluated multiple approaches (gene therapy, micro-RNA therapeutics) and chose the RNA-based approach because it "offered several advantages." These likely include: - ...
Synthetic Biology (in gene therapy context)
**What it means:** Synthetic biology is the field of engineering biological components and systems that don't exist in nature. In gene therapy, this includes designing custom viral vectors, optimizing...
FDA Approval Precedent (for gene therapy)
**What it means:** The fact that seven AAV-based gene therapies have received FDA approval provides a regulatory pathway that the MEF2C gene therapy team can follow. FDA has extensive experience revie...
Transcription Factor
**What it means:** Imagine your DNA is a library of instruction manuals (genes). A transcription factor is like a **foreman** who walks through the library, finds the right manual, and tells the worke...